Post-doc, Department of Cancer Research
PhD in Immunology, Medical University of Vienna (Austria)
The effective recognition and clearance of stressed or malignant cells by the immune system plays a crucial role in diverse pathological settings. Previous reports point to a role of γ9δ2 T cells in the defense against cancer and various pathogens, the mechanisms, however, remain poorly defined. The aim of this project is to find regulators of γ9δ2 T cell mediated cell killing to fine-tune future therapeutic approaches with γ9δ2 T cells.
Principal Scientist, Department of Cancer Research
PhD in Biology, Max-Planck Institute for Biochemistry, Munich (Germany)
- Biologics/bispecific antibody concepts in cancer therapy and infection
- Innate immunity, γδT-cells, cancer cell signaling